Stay updated on LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the study details and related documents on the page.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new NIH funding/identifier (2016) was added to the study's identifiers, and the page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor site update. This change does not alter the study details or data displayed on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedDifference0.0%

- Check85 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating a deployed update to the site's software version from v3.6.2.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0, indicating a minor site update rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.